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Abstract
Background: Ventriculoperitoneal (VP) shunts are used for intracranial pressure management
and temporary cerebrospinal fluid (CSF) drainage. Infection of the central nervous system (CNS)
is a major cause of morbidity and mortality in patients with CSF shunts. The aim of the present
study was to evaluate the clinical features, pathogens, and outcomes of 22 patients with CSF shunt
infections collected over 4 years.
Methods: The patients with shunt insertions were evaluated using; age, sex, etiology of
hydrocephalus, shunt infection numbers, biochemical and microbiological parameters, prognosis,
clinical infection features and clinical outcome.
Results: The most common causes of the etiology of hydrocephalus in shunt infected patients
were congenital hydrocephalus-myelomeningocele (32%) and meningitis (23%). The commonest
causative microorganism identified was Staphylococcus (S.) aureus, followed by Acinetobacter spp., and
S. epidermidis.
Conclusion: In a case of a shunt infection the timely usage of appropriate antibiotics, according to
the antimicrobial susceptibility testing, and the removal of the shunt apparatus is essential for
successful treatment.
Background
Ventriculoperitoneal shunts are used for maintaining a
specific intracranial pressure and generally permanent,
but on occasion temporary CSF drainage [1-3]. The place-
ment and revision of VP shunts remains a mainstay in the
surgical treatment of hydrocephalus [4]. Infection is the
foremost complication of CSF shunt implantation
[1,2,4,5]. The incidence of CSF infection secondary to
ventriculostomy, shunt insertions has been quoted in pre-
vious reports as being between 2.2% and 39 % [1,3].
Many factors have been reported to be associated with
increased risk of infection, including the age of patient,
etiology of hydrocephalus, the type of shunt implanted,
and the surgeon's experience [2]. The treatment of shunt
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stay by 2 or 3 weeks and additional surgery [2,6].
The aim of the present study was to evaluate the clinical
features, pathogens, and outcomes of 22 patients with cer-
ebrospinal fluid (CSF) shunt infections collected over 4
years.
Methods
The study protocol was approved by the Pamukkale Uni-
versity Research Ethics Committee, Denizli, Turkey, and it
complied with the principles outlined in the Helsinki
Declaration [7]. Written informed consent was obtained
from each patient or a legally designated representative.
The clinical notes of 124 consecutive patients having CNS
shunt placement operation for various etiology between
2000 December and 2004 December were reviewed of
Pamukkale University, Medical School, Department of
Neurosurgery. Operations were performed by two neuro-
surgeons. One of them (B.C.) has a subspecialty on pedi-
atric neurosurgery. The patients with shunt insertions
were analyzed according to; age, sex, etiology of hydro-
cephalus, shunt infection numbers, prognosis, clinical
infection features and clinical outcome. Biochemical and
microbiological parameters were evaluated from the
patients' clinical notes and the notes of a specialist in
Infectious Diseases.
To define the shunt infected group, at least one of the fol-
lowing criteria was present: 1) the presence of an organ-
ism isolated from CSF culture; 2) the presence of fever
(>38,5°C) in the absence of other recognized causes, with
institution of appropriate antimicrobial treatment and
any of the following; increased white cell count (> 50%
polymorphonuclear leucocytes), increased protein and/or
decreased glucose (< 15 g/dl) in CSF, or organisms visible
on CSF Gram stain. While CSF infections within the initial
30 days of ventricular catheter insertion were considered
to be early, the infections which occur 30 days after the
insertion were considered as late.
Only one dose prophylactic antibiotic (cefuroxime or
ampicillin) was given perioperatively to the patients.
Results
Shunt placement operations in 124 patients had been
made in the investigation period. Twenty-six (20.9 %) of
these 124 patients were younger than two years old. The
median age of adult patients were 46 (7–72). The type of
the shunt used was a medium pressure type shunt (burr-
hole valve medium pressure, from Medtronic, California,
USA). Etiological profile of CNS shunt placement opera-
tions of 124 patients is exhibited in Table 1 Among these
124 patients, 22 (17.7 %) patients were determined as
shunt infected. Thirty shunt infection attacks were con-
firmed in these 22 patients. The group consists of 12
males and 10 females. Ten of the 22 patients were younger
than two years old. The remaining adult patients' average
age was 44.3 years. Clinical data of the 22 patients were
designated in Table 2. In our study group, while CSF infec-
tions of 14 patients were seen in the early period, infec-
tions of remaining 8 patients were seen in the late period.
Some of the children had another site infection (urinary
tract infection, bronchitis, etc.) and majority of adult
patients with comorbidities had hypertension, diabetes
mellitus and another site infection (urinary tract infec-
tion, pneumonia). During the study, Acinetobacter has
been isolated in both CSF and tracheal aspirates simulta-
neously in two patients. Similarly, E. coli in two patients
and Klebsiella pneumoniae in one patient have been iso-
lated in both urine and CSF. The most common causes of
the etiology of hydrocephalus in shunt infected patients
were congenital hydrocephalus- closed myelomenin-
gocele (32%) and meningitis (23%); than respectively
intracranial mass (23%), intracranial hemorrhage (9%),
trauma (9%) and intracranial abscess (4.5%). The intrac-
ranial abscess was localized on supratentorial region and
the causative microorganism was not identified.
From CSF cultures that were taken during each infection
attack in only 20 was a microorganism isolated. The most
common causative microorganism identified was S.
aureus, followed by Acinetobacter spp., and S. epidermidis
(Table 3).
Up to two-thirds of the shunt infected patients' fevers were
high (> 38.3°C). From the CSFs that were taken during
the 30 infection events, leucocytes counts were increased
in 12.
Each infection was treated with external ventriculostomy
drainage (EVD) and intravenous antibiotics. The staphy-
lococcus species were susceptible to oxacillin in 7 cases
and the 2 patients with a resistant S. aureus strain required
glycopeptide therapy. Three patients died from complica-
Table 1: Etiological profile of CNS shunt placement operations of 
124 patients
Etiology of hydrocephalus No. of Patients (%)
Congenital hydrocephalus-myelomeningocele 18 (14.6)
Meningitis- hydrocephalus 22 (17.8)
Intracranial mass 28 (22.5)
Intracranial hemorrhage 16 (12.9)
Trauma 11 (8.8)
Intracranial abscess 8 (6.5)
Other 21 (16.9)
Total 124 (100)Page 2 of 5
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shunt infection.
Discussion
A variety of different shunt systems have been evaluated
but ventriculoatrial (VA) and VP shunts have been
employed most widely in clinical practice [3]. VP shunt-
ing has become the diversion procedure of choice because
of its shorter operative time and the need for fewer revi-
sions than VA shunts [3]. Although all shunt implant pro-
cedures are associated with a high risk of infection and
subsequent mortality [8], the rate of infection does not
appear to differ greatly between VA and VP shunts [3].
In our patient' population, the majority of devices were
placed for congenital hydrocephalus-myelomeningocele.
Many studies suggest that the etiology of hydrocephalus
was correlated with infections; however, in our study, the
numbers of cases were insufficient to determine this issue
[2].
Children are more likely than adults to acquire shunt
infection, perhaps because of longer hospital stay, higher
skin bacterial concentrations, immature immune systems,
or more adherent strains of bacteria [9,3]. The rates of
infections that are experienced in infants less than 6
months of age are generally two to three times greater
than those observed in older children. However, a higher
incidence of shunt infections had also been found in the
geriatric population [2]. In this study, the shunt infections
appeared to be more frequent in the under 2 year-old pop-
ulation.
Early studies reported rates of CSF shunt infection ranging
from 1.5 to 39 %; however, during the past two decades
infection rates have dropped to 2–9 % [3]. In a recent
study in our country the rate of shunt infections was
reported to be 14.5 % [6].
Fever is the most common manifestation of CNS shunt
infections. Fever in a patient with CNS shunt should
always prompt suspicion of shunt infection. Presentation
by other non-specific symptoms such as nausea, vomiting,
malaise, headache and meningismus are variable [2,3,6].
Examination of CSF should be performed in all patients
with suspected shunt infection. Bacterial and fungal cul-
tures of CSF, in addition to blood culture, should be
obtained from these patients. Administration of antibiot-
ics to a patient with suspected shunt infection before
obtaining CSF culture reduces the likelihood of obtaining
a positive culture [9].
The bacteria responsible for most shunt infections are
commensal organisms with low virulence. As it appears
that intraoperative contamination by skin flora or air-
borne skin organisms are the most important mechanism
of infection of CSF shunts, efforts have been directed at
Table 2: Clinical data of the patients
Age-sex Etiology of hydrocephalus Interval between surgery and 
development of infection
Attack number Outcome
1 12 month – F Post meningitic hydrocephalus 5 day 2 Exitus
2 14 month – F Intracranial mass 4 month 1 Good
3 4 month – M Congenital hydrocephalus-myelomeningocele 16 day 1 Good
4 2 month – M Congenital hydrocephalus-myelomeningocele 3 day 2 Exitus
5 7 month – M Congenital hydrocephalus-myelomeningocele 3 month 2 Good
6 3 month – F Congenital hydrocephalus-myelomeningocele 4 day 1 Good
7 1 month – F Congenital hydrocephalus-myelomeningocele 38 day 1 Good
8 10 month – F Congenital hydrocephalus-myelomeningocele 4 month 1 Good
9 18 month -M Congenital hydrocephalus-myelomeningocele 45 day 2 Good
10 5 month – M Post meningitic hydrocephalus 8 day 2 Good
11 24 y – M Trauma 7 day 2 Good
12 36 y – F Trauma 3 day 1 Good
13 65 y – M Intracranial hemorrhage 12 day 1 Good
14 56 y – F Intracranial hemorrhage 2 month 1 Good
15 15 y – M Post meningitic hydrocephalus 21 day 1 Good
16 33 y – F Post meningitic hydrocephalus 5 day 1 Good
17 7 y – M Post meningitic hydrocephalus 11 day 1 Good
18 72 y – M Intracranial abscess 13 day 2 Good
19 45 y – M Intracranial mass 17 day 1 Good
20 59 y – M Intracranial mass 15 day 2 Exitus
21 51 y – F Intracranial mass 5 month 1 Good
22 69 y – F Intracranial mass 3 month 1 Good
M: Male, F: Female. y: yearPage 3 of 5
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nation of the operative field [3]. The organisms most fre-
quently causing infections of indwelling CNS prostheses
are the coagulase-negative staphylococci. The second
most frequent pathogen is S. aureus [2,3,10,11] Previously
published microbiologic profile of CSF shunt infections is
showed in Table 4. It should not be forgotten that the
cause of nosocomial meningitis and shunt infections are
predominantly gram-negative bacilli and microorganisms
of the Staphylococcus genus [6,10]. Gram negative enteric
bacteria and Pseudomonas spp. account for about 5–10 %
of infections and are associated with greater morbidity
and mortality [3]. In our study, the rate of Gram- negative
microorganisms was fairly higher It can be speculated
that, simultaneous infections in other parts of the body
which were caused by the same gram negative microor-
ganisms may be responsible for that higher incidence.
Contrary to the literature, where gram positive microor-
ganisms are found to predominate in the shunt infections,
in a recent study reported in our country the results are
similar to ours; the rate of gram negative and positive
microorganisms was approximately equal [6].
Recent studies in our country report that the most fre-
quent isolated organism of nosocomial meningitis is Aci-
netobacter baumannii [12,13]. Our cases had various
predisposing factors for resistant hospital acquired micro-
organisms such as following treatment in the intensive
care unit. Colonization with nosocomial pathogens,
broad spectrum antibiotic usage and serious underlying
disease were also contributory factors. Perioperative
prophylaxis is generally targeted on staphylococci. Host
defenses were also impaired, however, because of the for-
eign body nature of the shunt. In the time period of the
isolation of multi-drug resistant Acinetobacter spp. from
CSF culture there was isolation of the same microorgan-
ism from multiple sites in many patients in the intensive
care unit.
CSF shunt infections are usually difficult to treat with sys-
temic antibiotics alone [3,8]. In our practice the manage-
ment of infections associated with CNS shunts was
usually surgical removal of the shunt, temporary external
CSF drainage, parenteral antimicrobial therapy with shunt
replacement after the infection had been eradicated. This
approach is the same as other authors [3,8,14].
Antimicrobials given intrathecally should be constituted
in a preservative- free medium to reduce the risk of arach-
noiditis. Thus intraventricular antibiotic therapy should
be used only if there is a reason to believe that therapeutic
CSF concentrations cannot be achieved as a consequence
of severe scarring of the choroid plexus or if the antimicro-
bial of choice is known to have poor CSF penetration,
such as an aminoglycoside [3].
The use of perioperative prophylactics for shunt implanta-
tion procedures has been controversial [3,14]. Short-term
perioperative antimicrobial prophylaxis may be of benefit
in preventing shunt infections [3].
Conclusion
Infection remains the most serious complication of VP
shunt placement. Although the etiology of shunt infec-
tions is predominantly gram positive organisms in many
centers, our results show that infections with gram-nega-
tive bacteria form a significant species percentage in the
shunt infection in our center. We recommend that the
catheter should be inserted under aseptic techniques and
should not be replaced unless it is clinically demonstrated
such as CSF shunt dysfunction etc. In case of a catheter
infection, it is both necessary to remove the shunt and
commence the systemic antibiotic treatment. It should
also not be forgotten that the timely usage of appropriate
antibiotics according to the antimicrobial susceptibility
testing is essential for successful treatment.
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